Controversies in ophthalmology

Article

The full scientific programme for the March Congress is now available.

Macular surgery, whether to peel or not to peel the internal limiting membrane, surgical management of various macular pathologies, the effect of catarct on diabetic retinopathy and controversial cases in retinal detachment are just some of the headlines from the Scientific Programme of the World Congress on Controversies in Ophthalmology, which takes place in March in Prague.

The event is intended as forum for international experts to share and compare experiences in order to outline the potentially best treatments for patients within controversial areas. There is little available in the peer-reviewed literature on controversies in Ophthalmology, so there is a perceived need to enable an effective debate about unresolved issues, often resulting in agreed-upon answers supported by evidence-based medicine and expert opinion.

Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Ophthalmology. The Congress aims to reach the best answers currently possible and provide the clinician with reliable, up-to-date scientific solutions, based on the best existing evidence.

Members of OTEurope's Editorial Advisory Board will be chairing some of the debates.

To get the full programme click here

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.